C
Coral Laboratories Ltd
BSE:524506
Coral Laboratories Ltd
BSE:524506
Price:
449.45
INR
4.83%
Market Closed
Market Cap:
₹1.6B
Relative Value
The Relative Value of one CORALAB stock under the Base Case scenario is hidden INR. Compared to the current market price of 449.45 INR, Coral Laboratories Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CORALAB Relative Value
HIDDEN
Multiples Across Competitors
CORALAB Competitors Multiples
Coral Laboratories Ltd Competitors
Coral Laboratories Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
C
|
Coral Laboratories Ltd
BSE:524506
|
1.6B INR | 1.8 | 11.5 | 5.1 | 6.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
866.9B USD | 13.3 | 42 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.1B USD | 6 | 21.2 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218B GBP | 4.9 | 28.4 | 15.8 | 22.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.3B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.4 | 9.6 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
240.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.9B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
